215 related articles for article (PubMed ID: 35885991)
21. Deep sequencing analysis of transcriptomes in Aspergillus oryzae in response to salinity stress.
He B; Ma L; Hu Z; Li H; Ai M; Long C; Zeng B
Appl Microbiol Biotechnol; 2018 Jan; 102(2):897-906. PubMed ID: 29101425
[TBL] [Abstract][Full Text] [Related]
22. Anti-tumour activity of two novel compounds in cisplatin-resistant testicular germ cell cancer.
Nitzsche B; Gloesenkamp C; Schrader M; Hoffmann B; Zengerling F; Balabanov S; Honecker F; Höpfner M
Br J Cancer; 2012 Nov; 107(11):1853-63. PubMed ID: 23169338
[TBL] [Abstract][Full Text] [Related]
23. Anti-angiogenic alternatives to VEGF blockade.
Khan KA; Bicknell R
Clin Exp Metastasis; 2016 Feb; 33(2):197-210. PubMed ID: 26620208
[TBL] [Abstract][Full Text] [Related]
24. Characterization of molecular and functional alterations of tumor endothelial cells to design anti-angiogenic strategies.
Bussolati B; Deregibus MC; Camussi G
Curr Vasc Pharmacol; 2010 Mar; 8(2):220-32. PubMed ID: 19485921
[TBL] [Abstract][Full Text] [Related]
25. Anti-angiogenic and pro-apoptotic effects of a small-molecule JFD-WS in in vitro and breast cancer xenograft mouse models.
Rathinavelu A; Kanagasabai T; Dhandayuthapani S; Alhazzani K
Oncol Rep; 2018 Apr; 39(4):1711-1724. PubMed ID: 29436685
[TBL] [Abstract][Full Text] [Related]
26. Oncometabolites lactate and succinate drive pro-angiogenic macrophage response in tumors.
Kes MMG; Van den Bossche J; Griffioen AW; Huijbers EJM
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188427. PubMed ID: 32961257
[TBL] [Abstract][Full Text] [Related]
27. The oncometabolite d‑2‑hydroxyglutarate induces angiogenic activity through the vascular endothelial growth factor receptor 2 signaling pathway.
Seok J; Yoon SH; Lee SH; Jung JH; Lee YM
Int J Oncol; 2019 Feb; 54(2):753-763. PubMed ID: 30483760
[TBL] [Abstract][Full Text] [Related]
28. Angiotensin-(1-7) reduces proliferation and angiogenesis of human prostate cancer xenografts with a decrease in angiogenic factors and an increase in sFlt-1.
Krishnan B; Torti FM; Gallagher PE; Tallant EA
Prostate; 2013 Jan; 73(1):60-70. PubMed ID: 22644934
[TBL] [Abstract][Full Text] [Related]
29. Single-Cell Transcriptome Analyses Reveal Endothelial Cell Heterogeneity in Tumors and Changes following Antiangiogenic Treatment.
Zhao Q; Eichten A; Parveen A; Adler C; Huang Y; Wang W; Ding Y; Adler A; Nevins T; Ni M; Wei Y; Thurston G
Cancer Res; 2018 May; 78(9):2370-2382. PubMed ID: 29449267
[TBL] [Abstract][Full Text] [Related]
30. Balance of pro- versus anti-angiogenic splice isoforms of vascular endothelial growth factor as a regulator of neuroblastoma growth.
Peiris-Pagès M; Harper SJ; Bates DO; Ramani P
J Pathol; 2010 Oct; 222(2):138-47. PubMed ID: 20662003
[TBL] [Abstract][Full Text] [Related]
31. Developing and applying a gene functional association network for anti-angiogenic kinase inhibitor activity assessment in an angiogenesis co-culture model.
Chen Y; Wei T; Yan L; Lawrence F; Qian HR; Burkholder TP; Starling JJ; Yingling JM; Shou J
BMC Genomics; 2008 Jun; 9():264. PubMed ID: 18518970
[TBL] [Abstract][Full Text] [Related]
32. Paradoxic effects of metformin on endothelial cells and angiogenesis.
Dallaglio K; Bruno A; Cantelmo AR; Esposito AI; Ruggiero L; Orecchioni S; Calleri A; Bertolini F; Pfeffer U; Noonan DM; Albini A
Carcinogenesis; 2014 May; 35(5):1055-66. PubMed ID: 24419232
[TBL] [Abstract][Full Text] [Related]
33. Azaindole derivatives are inhibitors of microtubule dynamics, with anti-cancer and anti-angiogenic activities.
Prudent R; Vassal-Stermann É; Nguyen CH; Mollaret M; Viallet J; Desroches-Castan A; Martinez A; Barette C; Pillet C; Valdameri G; Soleilhac E; Di Pietro A; Feige JJ; Billaud M; Florent JC; Lafanechère L
Br J Pharmacol; 2013 Feb; 168(3):673-85. PubMed ID: 23004938
[TBL] [Abstract][Full Text] [Related]
34. 'Accidental' anti-angiogenic drugs. anti-oncogene directed signal transduction inhibitors and conventional chemotherapeutic agents as examples.
Kerbel RS; Viloria-Petit A; Klement G; Rak J
Eur J Cancer; 2000 Jun; 36(10):1248-57. PubMed ID: 10882863
[TBL] [Abstract][Full Text] [Related]
35. Gene-expression Profiling in Patients with Plasma Cell Myeloma Treated with Novel Agents.
Medinger M; Halter J; Heim D; Buser A; Gerull S; Lengerke C; Passweg J
Cancer Genomics Proteomics; 2016; 13(4):275-9. PubMed ID: 27365377
[TBL] [Abstract][Full Text] [Related]
36. Identification of potential biomarkers and metabolic pathways based on integration of metabolomic and transcriptomic data in the development of breast cancer.
Yang Y; Zhu Y; Li X; Zhang X; Yu B
Arch Gynecol Obstet; 2021 Jun; 303(6):1599-1606. PubMed ID: 33791842
[TBL] [Abstract][Full Text] [Related]
37. Angiogenesis-related gene expression profile in clinical cases of canine cancer.
Tanabe A; Kobayashi D; Maeda K; Taguchi M; Sahara H
Vet Med Sci; 2019 Feb; 5(1):19-29. PubMed ID: 30265453
[TBL] [Abstract][Full Text] [Related]
38. Uncovering the antitumor effects and mechanisms of Shikonin against colon cancer on comprehensive analysis.
Chen Y; Si L; Zhang J; Yu H; Liu X; Chen Y; Wu Y
Phytomedicine; 2021 Feb; 82():153460. PubMed ID: 33476976
[TBL] [Abstract][Full Text] [Related]
39. Insulin-like growth factor binding protein-4 (IGFBP-4) is a novel anti-angiogenic and anti-tumorigenic mediator secreted by dibutyryl cyclic AMP (dB-cAMP)-differentiated glioblastoma cells.
Moreno MJ; Ball M; Andrade MF; McDermid A; Stanimirovic DB
Glia; 2006 Jun; 53(8):845-57. PubMed ID: 16586492
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
